Guidelines For Clinical Practice
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. Jun 16, 2012; 4(6): 241-246
Published online Jun 16, 2012. doi: 10.4253/wjge.v4.i6.241
Post-endoscopic retrograde cholangiopancreatography complications: How can they be avoided?
Juan J Vila, Everson LA Artifon, Jose Pinhata Otoch
Juan J Vila, Endoscopy Unit, Gastroenterology Department, Complejo Hospitalario de Navarra, Pamplona 31008, Spain
Everson LA Artifon, Associate Professor of Surgery, University of Sao Paulo, Sao Paulo 04304-030, Brazil
Jose Pinhata Otoch, Associate Professor of Surgery, University of Sao Paulo, Sao Paulo 04304-030, Brazil
Author contributions: Vila JJ drafted the article; Artifon ELA and Otoch JP critically reviewed the article.
Correspondence to: Juan J Vila, MD, Endoscopy Unit, Gastroenterology Department, Complejo Hospitalario de Navarra, Pamplona 31008, Spain. juanjvila@gmail.com
Telephone: +34-848-422114 Fax: +34-848-422303
Received: September 16, 2011
Revised: February 23, 2012
Accepted: May 27, 2012
Published online: June 16, 2012
Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) has a significant complication rate which can be lowered by adopting technical variations of proven beneficial effect and prophylactic maneuvers such as pancreatic stenting during ERCP or periprocedural non-steroidal anti-inflammatory drug administration. However, adoption of these prophylactic maneuvers by endoscopists is not uniform. In this editorial we discuss the beneficial effects of the aforementioned maneuvers.

Keywords: Acute necrotizing; Anti-inflammatory Agents; Catheterization; Cholangiopancreatography; Complications; Endoscopic retrograde; Non-steroidal; Pancreatitis; Stents